Contribution of ICG Angiography in the Detection of Parathyroids and the Prevention of Hypoparathyroidism Post Total Thyroidectomy
Key facts
- Who runs it
- University Hospital, Brest
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- Phase
- Phase 3
- People taking part
- 242 people, planned
- Started
- 22 Jun 2021
- Expected to end
- 22 Jun 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- ICG
- Control group
- Record updated
- 19 March 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Patient having to undergo a total thyroidectomy
- Signed consent
- Patient beneficiary of a social security regimen
Who cannot take part
- History of thyroid or parathyroid surgery
- Known allergy to ICG
- Minor patient under 18 years old
- Woman of child-bearing age not using adequate method of contraception
- Major patient protected by law or unable to give informed consent
- Pregnant or breastfeeding woman
- Thyroidectomy totalization
- Participation refusal
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
* Hypoparathyroidism is the most common complication after a total thyroidectomy surgery. It becomes permanent after 6 months. * Untreated permanent hypoparathyroidism is a source of numerous complications in general and therefore requires lifelong replacement therapy resulting in a significant deterioration in quality of life. * The intraoperative use of indocyanine green (ICG) angiography has recently been described as a reliable means of detecting parathyroidism and predicting the risk of postoperative hypoparathyroidism. * This use could prove to be a way to preserve parathyroid in vivo and thus reduce post-operative hypoparathyroidism rates.
The 2 groups in the trial
- ICG groupTreatment being tested
Patient receiving 2 or 3 intraoperative injections of indocyanine green.
Treatment: ICG
- Control groupOther group
Patient benefiting from the traditional surgical act
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Contribution of Indocyanine Green Angiography in the Detection of Parathyroids and the Prevention of Hypoparathyroidism Post Total Thyroidectomy
- Record updated
- 19 March 2026